[Tissue concentrations of pepleomycin following insertion of a cervical suppository in cases of uterine cancer].
D001761:Bleomycin / Q000008:administration & dosage / Q000378:metabolism*; D002584:Cervix Uteri; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D017663:Peplomycin; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage*; D013488:Suppositories; D014018:Tissue Distribution; D002583:Uterine Cervical Neoplasms / Q000628:therapy*
D011838:Radiation-Sensitizing Agents; D013488:Suppositories; D001761:Bleomycin; D017663:Peplomycin